Evidence map›Paper›PMID 41934498›Full record

ArticleJournal of computer-aided molecular design2026

Identification of potential inhibitors of 3‑mercaptopyruvate sulfurtransferase with a deep-learning based screening of natural products.

Changkang Wang, Xiao Chen, Yu Yin, Huimin Ding, Zhensuo Sha, Yifan Zhu, Xin Xue, Dongliang Zhang

Abstract read
In one paragraph

Article in Journal of computer-aided molecular design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Changkang Wang *Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Xiao Chen *Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Yu YinNanjing University of Chinese Medicine, Nanjing, 210023, China.
Huimin DingNanjing University of Chinese Medicine, Nanjing, 210023, China.
Zhensuo ShaNanjing University of Chinese Medicine, Nanjing, 210023, China.
Yifan ZhuNanjing University of Chinese Medicine, Nanjing, 210023, China.
Xin XueNanjing University of Chinese Medicine, Nanjing, 210023, China.
Dongliang ZhangNanjing University of Chinese Medicine, Nanjing, 210023, China. 202050117@njucm.edu.cn.

Funding

Jiangsu Province Traditional Chinese Medicine Technology Development Plan Project Project No. YB201976Zhenjiang Innovation Capacity Building Plan - Zhenjiang TCM Spleen and Stomach Disease Clinical Medical Research Center Project No. SS2021005
6 · The paper itself

Abstract

3-Mercaptopyruvate sulfurtransferase (3-MST), a key enzyme in sulfur metabolism, has recently gained attention as a potential anticancer target. However, reported 3-MST inhibitors remain limited, motivating the exploration of new scaffolds such as natural products. In this study, a library of 3744 natural products was virtually screened against human 3-MST using DiffDock (diffusion-model-based docking) followed by AutoDock Vina docking. Top-ranking candidates were further analyzed via molecular dynamics simulations and Molecular Mechanics Poisson-Boltzmann Surface Area binding free energy calculations. Methylophiopogonanone A (4), Daphnoretin (5), and L-asarinin (9) exhibited stable binding with favorable energetics, displaying binding free energies comparable to the reference ligand 7NC301. Binding mode analyses revealed that Methylophiopogonanone A primarily engaged in hydrophobic interactions, whereas Daphnoretin and L-asarinin formed extensive polar contacts, accompanied by higher desolvation penalties. In vitro cytotoxicity assays showed that Methylophiopogonanone A and L-asarinin reduced HCT116 cell viability by 40.3% and 26.3% at 25 µM, which is consistent with their inhibitory of 3-MST with IC

Indexed as

Antineoplastic AgentsBiological ProductsDeep LearningEnzyme InhibitorsSulfurtransferasesHumansLigandsMolecular Docking SimulationMolecular Dynamics Simulation3-mercaptopyruvate sulphurtransferaseAntineoplastic AgentsBiological ProductsEnzyme InhibitorsLigandsSulfurtransferases3-MSTColon cancerDeep learningMM-PBSANatural products

Identifiers

PMID41934498
PMCPMC13050340

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.